Minerva Neurosciences (NASDAQ:NERV) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a report released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright dropped their target price on shares of Minerva Neurosciences from $11.00 to $7.00 and set a neutral rating for the company in a […]
More Stories
Robertson Stephens Wealth Management LLC Sells 6,152 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Robertson Stephens Wealth Management LLC lowered its holdings in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 7.9% during the first...
Inscription Capital LLC Invests $82,000 in FREYR Battery, Inc. (NYSE:FREY)
Inscription Capital LLC purchased a new stake in FREYR Battery, Inc. (NYSE:FREY – Free Report) in the 1st quarter, according...
Insider Selling: Workday, Inc. (NASDAQ:WDAY) Major Shareholder Sells 15,000 Shares of Stock
Workday, Inc. (NASDAQ:WDAY – Get Free Report) major shareholder David A. Duffield sold 15,000 shares of the firm’s stock in...
JPMorgan Chase & Co. (NYSE:JPM) Holdings Lowered by Berkshire Bank
Berkshire Bank trimmed its stake in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 2.4% during the...
Robertson Stephens Wealth Management LLC Reduces Position in CVS Health Corporation (NYSE:CVS)
Robertson Stephens Wealth Management LLC reduced its position in CVS Health Corporation (NYSE:CVS – Free Report) by 15.2% during the...
Strategic Advisors LLC Lowers Stock Position in JPMorgan Chase & Co. (NYSE:JPM)
Strategic Advisors LLC cut its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 8.9% in the first quarter,...